In a phase 2 study, the company's medication suzetrigine barely performed better than a placebo in treating painful ...

Q4 2024 Earnings Call Transcript February 13, 2025 Vanda Pharmaceuticals Inc. beats earnings expectations. Reported EPS is ...

Kaitlyn Dever has quickly emerged as one of the standout stars of her generation, establishing herself as one of the most ...

Strong early U.S. YORVIPATH® launch with 908 prescriptions as of Feb. 7, 2025; YORVIPATH full year 2024 revenue of €28.7 million - Following pre-NDA meeting with FDA, on track to submit TransCon CNP ...

Glenmark reported a consolidated net profit of 3.48 billion rupees (USD 40.15 million) for the quarter ended December 31.

Biogen’s disappointing Leqembi performance and weak pipeline hurt future growth. Learn why BIIB stock is rated "sell" due to ...

Unlicensed pharmacies purporting to sell pharmaceutical drugs are thriving despite the efforts by the U.S. Drug Enforcement Administration to stop them.

Towa Pharmaceutical Co., Ltd. (OTCMKTS:TWAPF – Get Free Report) was the recipient of a large drop in short interest in January. As of January 31st, there was short interest totalling 18,300 shares, a ...

Basel: Roche, announced that the U.S. Food and Drug Administration (FDA) has approved a New Drug Application (NDA) for an ...

Sosei Group Corporation ( ($SOLTF) ) has released its Q4 earnings. Here is a breakdown of the information Sosei Group Corporation presented to its ...

Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino; “Ono”) announced that the U.S. Food and Drug Administration (FDA) has approved ROMVIMZA™ (vimseltinib), a kinase ...

Annoyed over Union health ministry decision, BDPMA to approach state govt for support of local pharma companies: Peethaambaran Kunnathoor, Chennai Saturday, February 15, 2025, 08: ...